🇺🇸 Calcium channel blocker strategy in United States

Calcium channel blocker strategy (Calcium channel blocker strategy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Calcium channel blocker strategy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Calcium channel blocker strategy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Calcium channel blocker strategy in United States?

Boston University is the originator. The local marketing authorisation holder may differ — check the official source linked above.